The present study i n v e s t i g a t e s t h e r e l a t i v e importance of a lt e r i n g O2 content and/or hemoglobin O2 a f f i n i t y (P50) i n changing cardiac output (C.O.) and O2 delivery t o t h e t i s s u e s . 1 8 newborn (NB) lambs were divided i n t o 3 groups. Blood gases, CH~J, P50 (mm Hg), regional blood flow (ml/min/lOOg t i s s u e ) and C.O. (mllminlkg) were measured before and 2 h r s a f t e r a l t e r a t i o n of O2 a f f i n i t y and/or content by means of exchange transfusing t h e lambs with f e t a l or maternal blood of varying Hct. O2 content was increased 38% i n Gr 1 (n=6) with no change i n P 5 0 0 content and P50 were increased 9% and 32% i n Gr 2 (n=5), and 388 and 32% i n Gr 3 (n=7), respectively. C.O. decreased 39% (364-221), 45% (324-177) and 48% (318-166) i n groups 1 , 2 and 3, respectively. Systemic O2 delivery decreased 22% i n Gr 2 (52.9-32.4) and 26% i n G r 3 (45-33) and was unchanged i n G r 1. PV02 increased i n Gr 2 from 31.8 t o 34.6 and i n Gr 3 from 23.4 t o 32.3. 0 consumption was unchanged i n a l l groups. These data suggest t g a t i n t h e N B lamb an increased P50 associated with increased Hct provides t h e same reduction of C.O. a s a 4-fold increased Hct without change i n P50. Higher increase i n 02 content provides no f u r t h e r reduction i n C.O. but a g r e a t e r increase i n PV02, suggesting enhanced O2 a v a i l a b i l i t y t o t h e t i s s u e s . These d a t a suggest t h a t t h e combined e f f e c t of increased P50 and increased O2 content achieves optimal 02 delivery, presumably a t t h e g r e a t e s t economy of t h e cardiovascular system.
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THERAPY OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

(ALL') USING ADRIAMYCIN (ADR) WITH OR WITHOUT HI GH DOSE ASPARAGINASE (ASP)
. Stephen E. Sallan, Sidney Farber Cancer I n s t i t u t e , Boston, MA.
We i n i t i a t e d a protocol f o r non-T-cell childhood ALL t h a t used q 3 weekly ADR. A random h a l f o f patients ( p t s ) also received high dose ASP q 1 week f o r 6 months. A l l patients received cranial r a d i a t i o n and i n t r a t h e c a l methotrexate (MTX). A f t e r comp l e t i n g ADR, q 3 weekly pulses of MTX and 6-mercaptopurine were begun. Therapy was e l e c t i v e l y discontinued a f t e r the completion of 30 months. Seventy-four p t s entered remission between 1977 and 1979. After randomization there were two 36-pt groups: A) ADR without ASP; B) ADR w i t h ASP. The groups were comparable i n age and white blood count. However, Grp A had 11/13 patients whose lymphoblasts lacked the conunon ALL antigen. I n Grp A 16/36 I p t s had f a i l e d compared t o Grp B 9/36. The median time t o f a i l u r e f o r Grp A was 28 months and disease-free survival i n Grp B i s 62%.
The difference between the groups i s n o t s t a t i s t i c a l l y s i g n i f icant, but the trend i s apparent. Of the failures i n Grp A, 15/16 relapsed; 11 i n the bone marrow (BM) only, 1 i n the central nervous system (CNS) and 3 i n the BM/CNS. Of the 9 Grp B f a i l u r e s , , 6 were relapses ( 3 BM, 1 t e s t i c l e , 2 CNS). Four children died i n remission: 3 o f adrianycin cardiomyopathy and 1 of sepsis. E f f o r t s t o decrease t o x i c i t y involve p r e d i c t i o n o f cardiac t o x ic i t y by the measurement o f the myocardial c o n t r a c t i l e s t a t e (methoxamine stress t e s t i n g ) and pharmacologic studies o f ADRIASP interactions. Further t r i a l s o f therapy using high dose ASP f o r prolonged periods o f treatment i n childhood ALL appear warrented. Five r e c i p i e n t s of BMT a t t h e Children's Hospital of Philadelphia developed l a t e b a c t e r i a l i n f e c t i o n s . This prompted us t o review our c l i n i c a l experience seeking evidence f o r s p l e n i c hypofunction i n those and o t h e r p a t i e n t s ( p t s ) . Accordingly, we sought Howell-Jolly bodies (HJB) i n peripheral blood smears of 29 p t s ; performed liver-spleen scans (LSS) i n 9 p t s with chronic graft-vs-host disease (CGVHD) and/or i n f e c t i o n ; and reviewed t h e spleens of 7 p t s who died and had autopsies. I n our s e r i e s a s a whole, 12 p t s developed GVHD (5 acute; 2 chronic; 5 a c u t e and chronic). 7/29 p t s developed HJB; 4 of these had GVHD. Four p t s receiving LSS showed decreased o r absent s p l e n i c function; 3 had GVHD. The incidence of HJB o r decreased function on LSS was not r e l a t e d t o underlying diagnosis o r preparative regimen. Lymphoid depletion was evident on a l l 7 spleens whose histopathology was reviewed: 2 showed t o t a l ; 3 marked; and 2 moderately depleted lymphoid t i s s u e . Our r e t r o s p e c t i v e data suggest t h a t s p l e n i c hypofunction is f a i r l y common i n t h e r e c i p i e n t s of BMT, especia l l y i n p t s with GVHD. Prospective s t u d i e s performed a t regular i n t e r v a l s a f t e r BMT w i l l be necessary t o d e f i n e the t r u e i n c idence of t h i s condition and i d e n t i f y those p t s who may need prophylactic a n t i b i o t i c therapy.
FAMILIAL HISTIOCYTOSIS I N OFFSPRING OF ARTIFICIALLY
With new technology now a v a i l a b l e f o r " a r t i f i c i a l l y " inducing pregnancy, r e s p o n s i b i l i t i e s f o r the outcome of these pregnancies a r i s e . W e report the occurrence of f a t a l malignant h i s t i o c y t o s i s i n 2 s i b l i n g s , the products of pregnancies r e s u l t i n g from insemi n a t i o n by t h e same sperm donor. The f i r s t , a female, became ill a t 3 months of age with a c o n s t e l l a t i o n of c l i n i c a l findings including fever, hepatosplenomegaly, pancytopenia, CSF pleocytosis and s e i z u r e s , dying a t 16 months of age. The second, a male, was conceived during h i s s i b ' s i l l n e s s which was f e l t not t o be inh e r i t e d . His i l l n e s s , beginning a t 2 months, was characterized by fever, hepatosplenomegaly, pancytopenia, CSF pleocytosis, and type I V hyperlipoproteinemia. Death occurred a t 4 months from Pseudomonas s e p s i s . V i r a l c u l t u r e s from multiple s i t e s i n both children were negative. Autopsies demonstrated massive hepatosplenomegaly and lymphohistiocytic meningeal i n f i l t r a t e s i n each. The second s i b had notable lymphohistiocytic i n f i l t r a t e i n l i v e r and erythrophagocytosis i n l i v e r , spleen, and bone marrow. Both a r e thought t o be cases of f a m i l i a l erythrophagocytic lymphohist i o c y t o s i s , a r a r e and frequently f a t a l disease, presumably transmitted i n an autosomal recessive fashion. These cases ill u s t r a t e the necessity of caution i n u t i l i z i n g t h e same sperm donor when one s i b is a f f e c t e d with an unknown disorder, even i f t h e problem is presumed not t o be i n h e r i t e d . Until a diagnosis can be made with c e r t a i n t y , i t may be more prudent t o delay repeat insemination o r t o s e l e c t a d i f f e r e n t donor. Children's Hospital of Pittsburgh,Dept.of P e d i a t r i c s , P i t t s b u r g h Nineteen children (median age 2 y r s ) undergoing chemotherapy f o r malignancies had indwelling s i l a s t i c Broviac c a t h e t e r s (BC) placed i n t h e superior vena cava t o provide vascular access. The B C were i n place f o r a t o t a l of 85 patient-months (mean 4.5 mos/ p a t i e n t ) . There were 8 episodes of BC-related bacteremic i n f e c tions ( 1 episodell0.6 patient-months). The i n f e c t i o n s occurred from 3wks-6 mos a f t e r BCinsertion (median 7wks ). Presenting symptoms included fever i n a l l cases ( o f t e n a s Acyclovir fi-(2-hydroxyethoxymethy1)guanin~ i s an a c y c l i c nucleoside analogue with i n v i t r o a c t i v i t y against herpesviruses including v a r i c e l l a -z o s t e r v i r u s . Acyclovir has had l i t t l e toxic i t y except f o r occasional bullae secondary t o drug extravasation. W e report our uncontrolled experience with t h i s agent i n four children with acute lymphocytic leukemia i n remission and disseminated primary v a r i c e l l a with involvement of l i v e r , lungs, CNS, and evidence of myelosuppression and coagulopathy. Progressive organ dissemination of v a r i c e l l a was present i n each p a t i e n t , with new skin lesions i n 2, d e s p i t e t h r e e d a i l y infusions of adenine arabinoside (Ara-A).
Ara-A a s discontinued and I V acyclo-1 v i r begun a t t h e dose of 500 mg/M every 8 hours. C l i n i c a l improvement beginning within 24 hours of i n i t i a t i o n of acyclovir with subsequent complete recovery following 7-10 days of drug occurred i n 3 of 4 p a t i e n t s . The remaining p a t i e n t , who manifested t h e most severe CNS, hepatic, and pulmonary dysfunction, ceased developing new skin lesions a f t e r acyclovir was begun but showed continued CNS and pulmonary d e t e r i o r a t i o n with DIC, and died aft e r t h r e e days. W e observed no t o x i c i t y except f o r cutaneous b u l l a e i n one p a t i e n t . This experience suggests t h a t acyclovir may play a r o l e i n t h e treatment of disseminated primary v a r ic e l l a i n immunocompromised hosts. Further controlled therapeutic t r i a l s with t h i s agent a r e indicated.
